Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

Caocci, Giovanni
First
;
Mulas, Olga
Second
;
Efficace, Fabio;Nasa, Giorgio La
Last
2020-01-01

Files in This Item:
File Size Format  
LDL.pdf

open access

Type: versione editoriale
Size 655.55 kB
Format Adobe PDF
655.55 kB Adobe PDF View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie